The Chimeric (ASX:CHM) share price jumps 6% on patent success

Chimeric's shares are on the move this afternoon. Here's the details.

| More on:
Happy child jumping for joy.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Chimeric Therapeutics Ltd (ASX: CHM) share price has jumped 6% into the green during afternoon trade, and currently trades at 33.5 cents.

Chimeric shares are rallying after the company announced a key update regarding its CAR Technology.

Read on for more details.

What did Chimeric Therapeutics announce?

Chimeric advised that the European Patent Office has granted the company a patent covering its chimeric antigen receptor (CAR) technology.

CAR Therapy is being developed for patients with Glioblastoma, where it is currently being studied in a phase 1 trial at City of Hope Medical Centre in the US.

The patent covers "certain applications" of the CAR technology using cholorotoxin (CLTX), and also the company's clinical-stage label CHM 1101.

It was published in the "European Patent Bulletin dated September 22, 2021", according to Chimeric, under patent number EP 3,362,470 B1.

Effectively the patent grants protection for CAR over these "applications" that will use CLTX and CHM 1011 until 2036.

In addition, Chimeric also "holds the exclusive worldwide license" to commercialise the patent, and "related patent applications filed in other global territories" for the compound.

This is an important milestone for clinical-stage biotechnology companies, as they need to secure the rights to sell their compounds if they can successfully develop them.

Investors appear to love the news and are pushing the Chimeric Therapeutics share price towards its previous high of 35 cents on 7 September.

What did management say?

Speaking on the patent milestone, Chimeric's CEO and managing director, Jennifer Chow said:

We are pleased to see the continued advancement of the strong intellectual property portfolio underpinning Chimeric's CLTX CAR T program, on this occasion in a geography that holds significant market potential.

Chimeric share price snapshot

The Chimeric Therapeutics share price has had a very difficult year to date and has posted a return of 14% since listing in January.

However, over the last month, it has stepped a further 1.5% into the green and is also up another 3% this past week.

It is still early days for Chimeric, but it is still trading ahead of the S&P/ASX 200 index (ASX: XJO)'s year to date gain of 12%.

At the time of writing, Chimeric Therapeutics has a market capitalisation of $105 million.

The author Zach Bristow has no positions in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Adore Beauty, Domino's, DroneShield, and Universal Store shares are rising today

Not all shares are falling today. Why are these rising?

Read more »

Lion roaring in the wild, symbolising a rising Liontown share price.
Share Gainers

Here are the top 10 ASX 200 shares today

ASX investors once again pulled back from record highs today.

Read more »

Cheerful boyfriend showing mobile phone to girlfriend in dining room. They are spending leisure time together at home and planning their financial future.
Share Gainers

Why Accent, Dusk, Evolution Mining, and Zip shares are pushing higher today

These shares are having a great session. But why?

Read more »

Hands reaching high for a trophy with a sunset in the background.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another day and another record high for ASX shares this Wednesday.

Read more »

Woman looks amazed and shocked as she looks at her laptop.

Have you heard of this ASX gold stock? It's up 114% in 8 days!

Investors have sent the ASX gold stock flying higher in July. But why?

Read more »

A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
Share Gainers

Why Cettire, Core Lithium, Northern Star, and Step One shares are charging higher

These shares are having a good time on hump day. But why?

Read more »

A woman's hand draws a stylised 'Top Ten' on a projected surface.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to earth for ASX investors this Tuesday.

Read more »

A man sees some good news on his phone and gives a little cheer.
Share Gainers

Why EOS, Hub24, Integrated Research, and Kingsgate shares are pushing higher

These shares are having a strong session. But why?

Read more »